MANIPAL HEALTH ENTERPRI L (MANIPALHOS) Share Price Fall Streak Extends to Second Straight Session

MANIPAL HEALTH ENTERPRI L Share Price Fall Streak is now in focus after the stock closed lower for its second straight session, taking the cumulative decline across the streak to 4.89% from the streak start base price of Rs 762.5 on 2026-09-01. The stock was at Rs 725.25 at the time of writing, down 2.91% on the day, and the supplied data confirms the consecutive-lower-close pattern but does not establish a company-specific cause for the move.

Today’s session adds important context beyond a one-day decline. MANIPAL HEALTH ENTERPRI L closed below its previous close of Rs 747 after opening at Rs 750.25, touching an intraday high of Rs 750.3 and a low of Rs 723. Turnover stood at Rs 2.77 crore, while market capitalisation was Rs 1,00,297.51 crore. For readers tracking Stock Market Today and healthcare names on Univest, two consecutive lower closes matter because they show continued downside rather than an isolated session move.

MANIPAL HEALTH ENTERPRI L (MANIPALHOS) Share Price Fall Streak: Consecutive Decline Analysis

The close near the day low shows that selling pressure persisted through the session. The day range between Rs 750.3 and Rs 723 was Rs 27.3, and the stock ended well below both the open and the previous close. That keeps the focus on weakness in the current streak rather than on any single intraday rebound attempt.

What the Consecutive Declines Show

Two consecutive lower closes shift the discussion from a one-day move to a short streak pattern. In this case, the MANIPAL HEALTH ENTERPRI L Share Price Fall Streak has taken the stock from the streak start base price of Rs 762.5 on 2026-09-01 to Rs 725.25, translating into a cumulative decline of 4.89% across the second straight session.

That matters because a streak offers more context than a single day’s fall. A one-session drop can be noise; a second lower close shows that weakness persisted into the next trading session. Today’s loss of 2.91% also means the second leg of the streak was material on its own, rather than just a marginal extension.

For traders and long-term market participants alike, this sort of move typically attracts attention because it forces a reassessment of recent price behaviour against valuation, profitability and peer positioning. On Univest, that makes the next layer of analysis less about guessing a reason and more about checking how the current numbers compare within the healthcare universe.

MANIPAL HEALTH ENTERPRI L (MANIPALHOS) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 1,00,297.51 crore
P/E Ratio	110.12x
P/B Ratio	5.39x
ROE	12.95%
ROCE	13.93%
EPS	Rs 6.78
Book Value Per Share	Rs 138.69
Dividend Yield	0%

The supplied fundamentals show a large listed healthcare company trading at a P/E ratio of 110.12 and a P/B ratio of 5.39. ROE stands at 12.95%, while ROCE is 13.93%. EPS is Rs 6.78, book value per share is Rs 138.69 and dividend yield is 0. These figures are useful because the streak is happening in a stock that still carries a demanding valuation profile.

In short, the fundamental picture shows scale and profitability, but also a valuation that keeps investors attentive to how the stock behaves relative to the broader Hospital & Healthcare Services benchmark.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Hospital & Healthcare Services
Benchmark Scope	same industry
Company P/E Ratio	110.12x
Benchmark Median P/E	47.77x
Benchmark Average P/E	102.53x
Benchmark P/E Range	7.52x to 1,511.2x
Company P/B Ratio	5.39x
Benchmark Median P/B	4.12x
Benchmark Average P/B	4.71x
Company ROE	12.95%
Benchmark Median ROE	12.88%
Benchmark Average ROE	14.16%
Company ROCE	13.93%
Benchmark Median ROCE	15.77%
Benchmark Average ROCE	3.29%
Company Market Capitalisation	Rs 1,00,297.51 crore
Benchmark Median Market Cap	Rs 631.34 crore
Benchmark Average Market Cap	Rs 11,993.34 crore

The company’s P/E of 110.12 is above the industry median of 47.77 and also above the industry average of 102.53. Its P/B of 5.39 is above the benchmark median of 4.12 and the average of 4.71. ROE of 12.95% is slightly above the benchmark median of 12.88, while ROCE of 13.93% is below the median of 15.77. Market capitalisation of Rs 1,00,297.51 crore is far above the industry median of Rs 631.34 crore.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Apollo Hospitals Enterprise	APOLLOHOSP	1,27,397.52	60.3	13.01	23.54	21.73
Max Healthcare Institute	MAXHEALTH	99,176.87	67.27	8.97	14.53	14.97
Fortis Healthcare	FORTIS	68,550.2	65.63	6.77	11.32	14.07
Aster DM Healthcare	ASTERDM	65,881	207.39	13.31	9.32	11.46
Global Health	MEDANTA	39,853.52	70.41	9.52	15.12	19.38

Peer data shows the company remains one of the largest names in the group, with a market capitalisation below Apollo Hospitals and above Max Healthcare, Fortis Healthcare, Aster DM Healthcare and Global Health. Its P/E is higher than most peers in the table, while its P/B is lower than Apollo, Max, Aster and Global Health. Profitability is mixed rather than peer-leading on the supplied figures.

Why Investors Are Watching MANIPAL HEALTH ENTERPRI L

• The stock has closed lower for the second straight session, with a cumulative two-session decline of 4.89% from Rs 762.5 to Rs 725.25.
• Today’s fall was 2.91%, and the close came near the day low of Rs 723 after opening at Rs 750.25 and touching Rs 750.3.
• Valuation remains elevated with a P/E of 110.12 and P/B of 5.39.
• Profitability metrics remain relevant, with ROE at 12.95%, ROCE at 13.93%, EPS at Rs 6.78 and book value at Rs 138.69.
• The company operates in a benchmarked healthcare industry where its market cap is among the largest, making peer comparison important on Univest.

About MANIPAL HEALTH ENTERPRI L

MANIPAL HEALTH ENTERPRI L is part of the Healthcare sector and the Hospital & Healthcare Services industry. It sits within the listed hospital and healthcare services universe that includes Apollo Hospitals Enterprise, Max Healthcare Institute, Fortis Healthcare, Aster DM Healthcare and Global Health.

With a market capitalisation of Rs 1,00,297.51 crore, the company remains one of the largest names in its industry group. That scale is why the recent move draws attention in healthcare market news and stock comparison coverage.

Track MANIPAL HEALTH ENTERPRI L on Univest

On Univest, readers can track MANIPAL HEALTH ENTERPRI L with live market price updates, key valuation ratios, profitability metrics, 52-week levels, peer comparison data and broader healthcare sector context. For investors following the MANIPAL HEALTH ENTERPRI L Share Price Fall Streak, the platform also helps connect day-wise price action with fundamentals, benchmark positioning and ongoing stock analysis without speculation.

Frequently Asked Questions

Why is MANIPAL HEALTH ENTERPRI L in focus today?

Ans.  The stock is in focus because it has closed lower for the second straight session. Today it fell 2.91% to Rs 725.25, taking the cumulative two-session decline to 4.89% from the streak base price of Rs 762.5.

What is the current price of MANIPAL HEALTH ENTERPRI L?

Ans.  MANIPAL HEALTH ENTERPRI L was at Rs 725.25 in the supplied data snapshot. That was down Rs 21.75 from the previous close of Rs 747, marking a 2.91% decline during today’s trading session.

What does the second straight session decline indicate?

Ans.  Two consecutive lower closes indicate that weakness persisted beyond a single session. In this case, the stock moved from Rs 762.5 at the streak start to Rs 725.25, creating a cumulative decline of 4.89%.

Did the supplied data confirm any company-specific reason for the fall?

Ans.  No. The supplied data confirms the price pattern, including the second straight session decline and today’s 2.91% drop, but it does not establish any company-specific catalyst behind the continued weakness in the stock.

How did MANIPAL HEALTH ENTERPRI L trade during the day?

Ans.  The stock opened at Rs 750.25, touched an intraday high of Rs 750.3 and a low of Rs 723, then closed at Rs 725.25. That means it ended the session close to the day’s lower end.

What is the market capitalisation of MANIPAL HEALTH ENTERPRI L?

Ans.  The company’s market capitalisation stands at Rs 1,00,297.51 crore in the supplied dataset. That places it among the largest companies in the Hospital & Healthcare Services industry benchmark used for this comparison.

How is MANIPAL HEALTH ENTERPRI L valued versus its industry?

Ans.  The stock trades at a P/E of 110.12, above the industry median of 47.77 and also above the industry average of 102.53. Its P/B of 5.39 is likewise above the benchmark median of 4.12.

What do the profitability ratios show for MANIPAL HEALTH ENTERPRI L?

Ans.  The supplied figures show ROE at 12.95% and ROCE at 13.93%. ROE is slightly above the industry median of 12.88%, while ROCE is below the median of 15.77 in the same benchmark universe.

How does MANIPAL HEALTH ENTERPRI L compare with major peers?

Ans.  Its market capitalisation is below Apollo Hospitals but slightly above Max Healthcare. Its P/E of 110.12 is higher than Apollo, Max, Fortis and Global Health, while ROE and ROCE are mixed rather than peer-leading.

What key metrics should investors track next on Univest?

Ans.  Investors can monitor price action around the second straight session decline, along with P/E, P/B, ROE, ROCE, EPS of Rs 6.78, book value of Rs 138.69 and the stock’s position against healthcare peers.

Track MANIPAL HEALTH ENTERPRI L (MANIPALHOS) Share Price on Univest

Use MANIPAL HEALTH ENTERPRI L (MANIPALHOS) live share-price page,Univest top decliners screener,Univest market blogsto review live stock data, top decliners and related market analysis.